Ralph DeFronzo, MD, leads a discussion on the evolving perception of autonomous adrenal hypercortisolism, highlighting that its prevelance is significantly greater than previously understood.
Surge in New GLP-1 Prescriptions Driven by Semaglutide's Popularity, Study Shows
Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD
Mendelian Randomization Links T1D to Increased Risk of Arthritis, MS
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap
Semaglutide Can Preserve, Possibly Improve, NYHA Functional Class in Obesity-Related HFpEF
SGLT2 Inhibitor, GLP-1 RA Combination Improves Cardiovascular, Kidney Outcomes in Diabetes